In Silico

In Silico describes computational or computer-based approaches conducting experiments, simulations, analyses, or predictions using algorithms, mathematical models, and databases rather than physical laboratory techniques. This term encompasses diverse computational methods including molecular modelling, virtual screening, pharmacokinetic simulations, systems biology modelling, and bioinformatics analysing genomic or proteomic data.

The pharmaceutical industry increasingly integrates in silico methods throughout discovery and development, accelerating timelines and improving efficiency. Structure-based drug design employs molecular docking predicting ligand binding to protein targets, guiding optimisation toward improved affinity and selectivity. ADME prediction models estimate absorption, distribution, metabolism, and excretion properties guiding lead selection. Toxicity prediction identifies potential liabilities enabling early elimination of problematic compounds. Pharmacokinetic modelling simulates drug disposition predicting doses and regimens. As computational power increases, algorithms improve through machine learning, and biological databases expand, in silico approaches become increasingly sophisticated supporting more efficient, rational drug development.